Exclusivity & Patent Protection: Currently, Semaglutide GLP-1 is under patent protection, which can keep prices higher until generic or biosimilar alternatives become available
Croteau D, Luptak I, Chambers JM, Hobai I, Panagia M, Pimentel DR et al
However, dedicated kidney outcome trials for GLP-1 receptor agonists remain limited, and further long-term studies are needed to better define their role in CKD management
Pricing Disclaimer: All pricing information reflects publicly available data from brand and competitor websites at time of publication
If you are using Ozempic for diabetes management, you should monitor your blood sugar levels more frequently if you are taking a decongestant